E03.2 Billable / specific Hypothyroidism due to medicaments and other exogenous substances
ICD-10-CM E03.2 identifies “Hypothyroidism due to medicaments and other exogenous substances” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 4: Endocrine, nutritional and metabolic diseases
Code-level instructions
Code first1
poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
Use additional code1
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Inherited instructions
Chapters 4 · Endocrine, nutritional and metabolic diseases (E00-E89)
Excludes 11
transitory endocrine and metabolic disorders specific to newborn (P70-P74)
Note1
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
E03 · Other hypothyroidism
Excludes 12
- iodine-deficiency related hypothyroidism (E00-E02)
- postprocedural hypothyroidism (E89.0)
Official index references
Official index references (8)
Hypothyroidism(acquired) (8)
- Hypothyroidism(acquired) › due to › exogenous substance NECDisease index
- Hypothyroidism(acquired) › due to › medicament NECDisease index
- Hypothyroidism(acquired) › due to › P-aminosalicylic acid(PAS)Disease index
- Hypothyroidism(acquired) › due to › phenylbutazoneDisease index
- Hypothyroidism(acquired) › due to › resorcinolDisease index
- Hypothyroidism(acquired) › due to › sulfonamideDisease index
- Hypothyroidism(acquired) › due to › thiourea group drugsDisease index
- Hypothyroidism(acquired) › iatrogenic NECDisease index
History
Code history
Latest recorded change · FY2024
Effective from
- Code-level rules changed
Hypothyroidism due to medicaments and other exogenous substances
Billable diagnosis code
CDC/NCHS · FY2024All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Code-level rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Historical ICD-9 mappings · 2018
Historical mapping only; not an automatic code substitution.
- 244.2 · Approximate
- 244.3 · Approximate
This entry is a complete code in the selected edition. Reference checks do not establish clinical appropriateness or guarantee reimbursement.